Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures
Carol M Ulloa, Allen Towfigh, Joseph SafdiehDepartment of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY, USAAbstract: Levetiracetam is a second-generation antiepileptic drug (AED) with a unique chemical structure and mechanism of action. The extended release f...
Guardado en:
Autores principales: | Carol M Ulloa, Allen Towfigh, Joseph Safdieh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e44f6df13ed84c11b8e7bb96312495c7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety and efficacy of levetiracetam for the treatment of partial onset seizures in children from one month of age
por: Cormier J, et al.
Publicado: (2013) -
Monotherapy for partial epilepsy: focus on levetiracetam
por: Antonio Gambardella, et al.
Publicado: (2008) -
Lacosamide for the prevention of partial onset seizures in epileptic adults
por: Anna Kelemen, et al.
Publicado: (2010) -
Profile of perampanel and its potential in the treatment of partial onset seizures
por: Rheims S, et al.
Publicado: (2013) -
Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures
por: Weisenberg JLZ, et al.
Publicado: (2011)